SEC Form 4 · accession 0001358403-15-000030
BELLICUM PHARMACEUTICALS, INC · BLCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Reid M Huber
Director
Period of report
Jun 17, 2015
Accepted (ET)
Jun 19, 2015 · 5:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001358403
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $22.63 | Jun 17, 2015 | A | 10,000 | A | — | Jun 16, 2025 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1The option vests in twelve equal monthly installments following the grant date such that the option will be fully vested on the day immediately preceding the next annual meeting of stockholders of the Issuer.